In the present review, we first discuss the major role of AT1 in cerebrovascular diseases, before reviewing the preclinical and clinical studies showing the interest and limits of AT1 blockade with ARBs in such situations (with a particular emphasis on strokes). This evidence concerns the gene AGTR1 and Stroke.